Diagnosis of HIV-Associated Oral Lesions in Relation to Early versus Delayed Antiretroviral Therapy: Results from the CIPRA HT001 Trial

por Batavia, Ashita S., Secours, Rode, Espinosa, Patrice, Jean Juste, Marc Antoine, Severe, Patrice, Pape, Jean William, Fitzgerald, Daniel W.
Publicado 2016

High Accuracy of Common HIV-Related Oral Disease Diagnoses by Non-Oral Health Specialists in the AIDS Clinical Trial Group

por Shiboski, Caroline H., Chen, Huichao, Secours, Rode, Lee, Anthony, Webster-Cyriaque, Jennifer, Ghannoum, Mahmoud, Evans, Scott, Bernard, Daphné, Reznik, David, Dittmer, Dirk P., Hosey, Lara, Sévère, Patrice, Aberg, Judith A.
Publicado 2015

Cost-Effectiveness of Early Versus Standard Antiretroviral Therapy in HIV-Infected Adults in Haiti

por Koenig, Serena P., Bang, Heejung, Severe, Patrice, Jean Juste, Marc Antoine, Ambroise, Alex, Edwards, Alison, Hippolyte, Jessica, Fitzgerald, Daniel W., McGreevy, Jolion, Riviere, Cynthia, Marcelin, Serge, Secours, Rode, Johnson, Warren D., Pape, Jean W., Schackman, Bruce R.
Publicado 2011

Third‐line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 wee...

por Avihingsanon, Anchalee, Hughes, Michael D., Salata, Robert, Godfrey, Catherine, McCarthy, Caitlyn, Mugyenyi, Peter, Hogg, Evelyn, Gross, Robert, Cardoso, Sandra W., Bukuru, Aggrey, Makanga, Mumbi, Badal‐aesen, Sharlaa, Mave, Vidya, Ndege, Beatrice Wangari, Fontain, Sandy Nerette, Samaneka, Wadzanai, Secours, Rode, Van Schalkwyk, Marije, Mngqibisa, Rosie, Mohapi, Lerato, Valencia, Javier, Sugandhavesa, Patcharaphan, Montalban, Esmelda, Munyanga, Cornelius, Chagomerana, Maganizo, Santos, Breno R., Kumarasamy, Nagalingeswaran, Kanyama, Cecilia, Schooley, Robert T., Mellors, John W., Wallis, Carole L., Collier, Ann C., Grinsztejn, Beatriz
Publicado 2022